SCHEMBL6389593

SCHEMBL6389593

COc1ccc2[nH]c(C(=O)n3ccnc3)cc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.60
PDGFRA P16234 2/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
HRH4 Q9H3N8 1/20 0.58
FLT3 P36888 6/20 0.54
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
TSHR P16473 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
KDM4E B2RXH2 1/20 0.53
NPC1 O15118 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
RAB9A P51151 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
IDO1 P14902 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4815855 0.79 KDM4E (0.53) CYP1A2CYP3A4TSHRKDM4EALDH1A1
SCHEMBL6396188 0.79 FLT3 (0.54) HRH4FLT3KDM4EALDH1A1HPGD
SCHEMBL6866887 0.76 PDGFRB (1.00) PDGFRBPDGFRAMEN1KMT2AFLT3
SCHEMBL12334808 0.75 HRH4 (0.81) PDGFRBPDGFRAMEN1KMT2AHRH4
SCHEMBL10820775 0.75 KMT2A (1.00) MEN1KMT2ATSHRHDAC6KDM4E
SCHEMBL335235 0.75 PDGFRB (0.79) PDGFRBPDGFRAMEN1KMT2AFLT3
SCHEMBL2729934 0.75 PDGFRB (0.79) PDGFRBPDGFRAMEN1KMT2AFLT3
SCHEMBL10821170 0.74 KMT2A (0.94) MEN1KMT2ATSHRHDAC6KDM4E
SCHEMBL25667602 0.74 HRH4 (0.59) MEN1KMT2AHRH4FLT3HDAC6
SCHEMBL1429381 0.74 PDGFRB (0.77) PDGFRBPDGFRAMEN1KMT2AFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050267303-A1 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals ZENTARIS AG 2005-12-01 US disclosed
US-20040039197-A1 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals WATERWORKS, INC. 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050267303-A1 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals IDO1, IDO2, INMT PDGFRB 3507/4885PDGFRA 3410/4885MEN1 279/4885
US-20040039197-A1 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals IDO1, IDO2, INMT PDGFRB 3464/4885PDGFRA 3317/4885MEN1 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.